Found: 7
Select item for more details and to access through your institution.
Using macrophage activation to augment immunotherapy of established tumours.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 6, p. 1288, doi. 10.1038/bjc.2013.93
- By:
- Publication type:
- Article
Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 6, p. 1306, doi. 10.1038/bjc.2013.101
- By:
- Publication type:
- Article
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.
- Published in:
- Oncogene, 2013, v. 32, n. 7, p. 903, doi. 10.1038/onc.2012.99
- By:
- Publication type:
- Article
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.
- Published in:
- Cancer Gene Therapy, 2011, v. 18, n. 12, p. 871, doi. 10.1038/cgt.2011.56
- By:
- Publication type:
- Article
Eighth International Mesothelioma Interest Group.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 6959, doi. 10.1038/sj.onc.1210515
- By:
- Publication type:
- Article
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
- Published in:
- Gene Therapy, 2001, v. 8, n. 12, p. 946, doi. 10.1038/sj.gt.3301489
- By:
- Publication type:
- Article
Use of protamine to augment adenovirus-mediated cancer gene therapy.
- Published in:
- Gene Therapy, 1999, v. 6, n. 9, p. 1600, doi. 10.1038/sj.gt.3300987
- By:
- Publication type:
- Article